BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3585079)

  • 1. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
    Sugawara T
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
    Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
    Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
    Karino Y; Sugawara T; Saga A; Yoshida J; Matsushima T; Miyazaki T; Toyota J; Okuuchi Y
    Gastroenterol Jpn; 1989 Apr; 24(2):164-9. PubMed ID: 2744332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
    Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
    Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
    Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
    Daito K; Suou T; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
    Ogawa Y
    Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
    Giannelli G; Antonelli G; Fera G; Dianzani F; Schiraldi O
    J Interferon Res; 1993 Feb; 13(1):57-60. PubMed ID: 8454912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
    Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
    Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.
    Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K
    Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.
    Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y
    Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
    Komiyama T; Akaike M; Satomura K; Okumura H
    Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.